Published • loading... • Updated
Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies
Summary by Waterloo Cedar Falls Courier
16 Articles
16 Articles
+15 Reposted by 15 other sources
Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies
BLOOMFIELD HILLS, Mich. , March 31, 2026 /PRNewswire/ -- Vlasic Labs today announced that its CBD product line meets the current qualifications outlined in the Centers for Medicare & Medicaid Services (CMS) pilot program, a first-of-its-kind initiative allowing participating healthcare…
·Waterloo, United States
Read Full ArticleCoverage Details
Total News Sources16
Leaning Left0Leaning Right1Center10Last UpdatedBias Distribution91% Center
Bias Distribution
- 91% of the sources are Center
91% Center
C 91%
Factuality
To view factuality data please Upgrade to Premium






